Efficacy and safety of the monolconal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. - Panacek,E.A.; Marshall,J.C.; Albertson,T.E.; Johnson,D.H.; Johnson,S.; MacArthur,R.D.; Miller,M.; Barchuk,W.T.; Fischkoff,S.; Kaul,M. (Crit Care Med, 2004)